Reilly Rachel, McKetin Rebecca, Wand Handan, Butt Julia, Smout Matthew, Ezard Nadine, Conigrave Katherine, Clark Yvonne, Quinn Brendan, Treloar Carla, Gray Dennis, Dunlop Adrian, Roe Yvette, Ward James
Infectious Diseases Aboriginal Health, Aboriginal Health Equity, South Australian Health and Medical Research Institute, Adelaide, Australia.
College of Medicine and Public Health, Flinders University, Bedford Park, Australia.
JMIR Res Protoc. 2019 Jul 26;8(7):e14084. doi: 10.2196/14084.
Methamphetamine use is of deep concern to Aboriginal and Torres Strait Islander communities, but access to culturally appropriate treatment resources and services is limited. Web-based programs have potential as flexible and cost-effective additions to the range of treatment options available to Aboriginal people. The We Can Do This online intervention is designed to incorporate evidence-based therapies in a culturally relevant format using narratives from Aboriginal people to contextualize the therapeutic content.
The goal of the research will be to test the effectiveness of the online intervention in a wait-list controlled randomized trial across multiple sites in urban, regional, and remote locations.
Participants will be Aboriginal and Torres Strait Islander people aged 16 years and over who have used methamphetamine at least weekly for the previous 3 months. They will be recruited online and via health services. During the intervention phase, participants will have access to the online intervention for 6 weeks with optional telephone or face-to-face support provided by participating health services. The primary outcome measure will be the number of days the participant used methamphetamine over the past 4 weeks compared to wait-list controls, assessed at baseline, 1, 2, and 3 months. Secondary outcomes will include help-seeking, readiness to change, severity of dependence, and psychological distress. Any important changes to the protocol will be agreed upon by the trial management committee and communicated to all relevant parties, including trial site representatives and the trial registry.
Recruitment will commence in July 2019, and results are expected in early 2021. This research is funded by National Health and Medical Research Council project grant #1100696. The primary sponsor for the trial is the South Australian Health and Medical Research Institute. A trial management committee with representation from the participating health services, chief investigators, other Aboriginal experts, and consumers will oversee procedures, trial conduct, analysis, and reporting of the results.
The trial of this online intervention builds on existing research supporting the effectiveness of Web-based therapies for a range of psychological and other health-related issues including substance use. If successful, the We Can Do this online intervention will increase the range of options available to Aboriginal people seeking to reduce or stop methamphetamine use. It may provide a pathway into treatment for people who may otherwise be disengaged with health services for a range of reasons and will be a culturally appropriate, evidence-based resource for health practitioners to offer their clients.
Australian New Zealand Clinical Trials Registry ACTRN12619000134123p; https://www.anzctr.org.au/ Trial/Registration/TrialReview.aspx?id=376088&isReview=true.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/14084.
甲基苯丙胺的使用是原住民和托雷斯海峡岛民社区深切关注的问题,但获得符合文化需求的治疗资源和服务有限。基于网络的项目有潜力成为原住民可获得的一系列治疗选择中灵活且具成本效益的补充。“我们能做到”在线干预旨在采用原住民的叙述,以符合文化背景的形式纳入循证疗法,从而将治疗内容情境化。
本研究的目标是在一项等待名单对照的随机试验中,在城市、地区和偏远地区的多个地点测试该在线干预的有效性。
参与者将为年龄在16岁及以上、在过去3个月中至少每周使用一次甲基苯丙胺的原住民和托雷斯海峡岛民。他们将通过网络和卫生服务机构招募。在干预阶段,参与者将有6周时间使用在线干预,并可获得参与的卫生服务机构提供的可选电话或面对面支持。主要结局指标将是与等待名单对照相比,参与者在过去4周内使用甲基苯丙胺的天数,在基线、1个月、2个月和3个月时进行评估。次要结局将包括寻求帮助、改变的意愿、依赖的严重程度和心理困扰。方案的任何重要变更都将由试验管理委员会商定,并传达给所有相关方,包括试验地点代表和试验注册机构。
招募工作将于2019年7月开始,预计2021年初得出结果。本研究由澳大利亚国家卫生与医学研究委员会项目资助#1100696提供资金。该试验的主要赞助商是南澳大利亚卫生与医学研究所。一个由参与的卫生服务机构、首席研究员、其他原住民专家和消费者代表组成的试验管理委员会将监督程序、试验实施、分析和结果报告。
这项在线干预试验建立在现有研究的基础上,这些研究支持基于网络的疗法对包括药物使用在内的一系列心理和其他健康相关问题的有效性。如果成功,“我们能做到”在线干预将增加寻求减少或停止使用甲基苯丙胺的原住民可获得的选择范围。它可能为因各种原因可能与卫生服务脱节的人提供一条进入治疗的途径,并且将成为卫生从业人员向其客户提供的符合文化背景、基于证据的资源。
澳大利亚新西兰临床试验注册中心ACTRN12619000134123p;https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376088&isReview=true。
国际注册报告识别号(IRRID):PRR1-10.2196/14084。